1	Minimal	Minimal	B-NP	JJ	O	2	NMOD	0
2	contribution	contribution	I-NP	NN	O	0	ROOT	16	contribution
3	of	of	B-PP	IN	O	2	NMOD	0
4	marrow-derived	marrow-derived	B-NP	JJ	B-protein	6	NMOD	0
5	endothelial	endothelial	I-NP	JJ	I-protein	6	NMOD	0
6	precursors	precursor	I-NP	NNS	I-protein	3	PMOD	0
7	to	to	B-PP	TO	O	2	NMOD	0
8	tumor	tumor	B-NP	NN	O	9	NMOD	0
9	vasculature	vasculature	I-NP	NN	O	7	PMOD	0
10	.	.	O	.	O	2	P	0

1	During	During	B-PP	IN	O	8	VMOD	0
2	embryogenesis	embryogenesis	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	8	P	0
4	vascular	vascular	B-NP	JJ	O	7	NMOD	0
5	and	and	I-NP	CC	O	7	NMOD	0
6	hemopoietic	hemopoietic	I-NP	JJ	B-cell_type	7	NMOD	0
7	cells	cell	I-NP	NNS	I-cell_type	8	SUB	0
8	originate	originate	B-VP	VBP	O	0	ROOT	2	originate
9	from	from	B-PP	IN	O	8	VMOD	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	common	common	I-NP	JJ	O	12	NMOD	0
12	precursor	precursor	I-NP	NN	O	9	PMOD	0
13	,	,	O	,	O	8	P	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	hemangioblast	hemangioblast	I-NP	NN	B-cell_type	8	VMOD	0
16	.	.	O	.	O	8	P	0

1	Recent	Recent	B-NP	JJ	O	2	NMOD	0
2	evidence	evidence	I-NP	NN	O	3	SUB	0
3	suggests	suggest	B-VP	VBZ	O	17	VMOD	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	existence	existence	I-NP	NN	O	3	OBJ	14	existence
6	of	of	B-PP	IN	O	5	NMOD	0
7	endothelial	endothelial	B-NP	JJ	B-cell_type	8	NMOD	0
8	precursors	precursor	I-NP	NNS	I-cell_type	6	PMOD	0
9	in	in	B-PP	IN	O	5	NMOD	0
10	adult	adult	B-NP	JJ	B-cell_type	13	NMOD	0
11	bone	bone	I-NP	NN	I-cell_type	13	NMOD	0
12	marrow	marrow	I-NP	NN	I-cell_type	13	NMOD	0
13	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	0
14	,	,	O	,	O	17	P	0
15	but	but	O	CC	O	17	VMOD	0
16	it	it	B-NP	PRP	O	17	SUB	0
17	is	be	B-VP	VBZ	O	0	ROOT	0
18	unclear	unclear	B-ADJP	JJ	O	17	PRD	0
19	whether	whether	B-SBAR	IN	O	17	VMOD	0
20	those	those	B-NP	DT	O	21	NMOD	0
21	precursors	precursor	I-NP	NNS	O	22	SUB	0
22	have	have	B-VP	VBP	O	19	SBAR	0
23	a	a	B-NP	DT	O	24	NMOD	0
24	role	role	I-NP	NN	O	22	OBJ	0
25	in	in	B-PP	IN	O	22	VMOD	0
26	tumor	tumor	B-NP	NN	O	27	NMOD	0
27	neovascularization	neovascularization	I-NP	NN	O	25	PMOD	3	neovascularization
28	.	.	O	.	O	17	P	0

1	In	In	B-PP	IN	O	6	VMOD	0
2	this	this	B-NP	DT	O	3	NMOD	0
3	report	report	I-NP	NN	O	1	PMOD	0
4	,	,	O	,	O	6	P	0
5	we	we	B-NP	PRP	O	6	SUB	0
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	murine	murine	B-NP	JJ	O	10	NMOD	0
9	bone	bone	I-NP	NN	O	10	NMOD	0
10	marrow	marrow	I-NP	NN	O	11	SUB	0
11	contains	contain	B-VP	VBZ	O	7	SBAR	0
12	endothelial	endothelial	B-NP	JJ	B-cell_type	13	NMOD	0
13	progenitors	progenitor	I-NP	NNS	I-cell_type	11	OBJ	0
14	,	,	O	,	O	13	P	0
15	which	which	B-NP	WDT	O	13	NMOD	0
16	arise	arise	B-VP	VBP	O	15	SBAR	0
17	from	from	B-PP	IN	O	16	VMOD	0
18	a	a	B-NP	DT	O	19	NMOD	0
19	cell	cell	I-NP	NN	O	17	PMOD	0
20	with	with	B-PP	IN	O	19	NMOD	0
21	self-renewing	self-renewing	B-NP	JJ	O	22	NMOD	0
22	capacity	capacity	I-NP	NN	O	20	PMOD	0
23	,	,	O	,	O	6	P	0
24	and	and	O	CC	O	6	VMOD	0
25	can	can	B-VP	MD	O	6	VMOD	0
26	integrate	integrate	I-VP	VB	O	25	VC	0
27	into	into	B-PP	IN	O	26	VMOD	0
28	tumor	tumor	B-NP	NN	O	29	NMOD	0
29	microvasculature	microvasculature	I-NP	NN	O	27	PMOD	0
30	,	,	O	,	O	26	P	0
31	albeit	albeit	B-ADVP	IN	O	26	VMOD	0
32	at	at	B-PP	IN	O	31	PMOD	0
33	a	a	B-NP	DT	O	36	NMOD	0
34	very	very	I-NP	RB	O	35	AMOD	0
35	low	low	I-NP	JJ	O	36	NMOD	0
36	frequency	frequency	I-NP	NN	O	32	PMOD	0
37	.	.	O	.	O	6	P	0

1	A	A	B-NP	DT	O	4	NMOD	0
2	transgenic	transgenic	I-NP	JJ	O	3	AMOD	0
3	double-reporter	double-reporter	I-NP	JJ	O	4	NMOD	0
4	strategy	strategy	I-NP	NN	O	5	SUB	0
5	allowed	allow	B-VP	VBD	O	0	ROOT	0
6	us	us	B-NP	PRP	O	8	SUB	0
7	to	to	B-VP	TO	O	8	VMOD	0
8	demonstrate	demonstrate	I-VP	VB	O	5	VMOD	0
9	definitively	definitively	B-ADVP	RB	O	8	VMOD	0
10	that	that	B-SBAR	IN	O	8	VMOD	0
11	tumor	tumor	B-NP	NN	B-cell_type	15	NMOD	0
12	bone	bone	I-NP	NN	I-cell_type	15	NMOD	0
13	marrow-derived	marrow-derived	I-NP	JJ	I-cell_type	15	NMOD	0
14	endothelial	endothelial	I-NP	JJ	I-cell_type	15	NMOD	0
15	cells	cell	I-NP	NNS	I-cell_type	16	SUB	0
16	arise	arise	B-VP	VBP	O	10	SBAR	0
17	by	by	B-PP	IN	O	16	VMOD	0
18	transdifferentiation	transdifferentiation	B-NP	NN	O	17	PMOD	2	transdifferentiation
19	of	of	B-PP	IN	O	18	NMOD	0
20	marrow	marrow	B-NP	NN	B-cell_type	21	NMOD	0
21	progenitors	progenitor	I-NP	NNS	I-cell_type	19	PMOD	0
22	rather	rather	B-CONJP	RB	O	18	NMOD	0
23	than	than	I-CONJP	IN	O	22	DEP	0
24	by	by	B-PP	IN	O	22	DEP	0
25	cell	cell	B-NP	NN	O	26	NMOD	0
26	fusion	fusion	I-NP	NN	O	24	PMOD	2	fusion
27	.	.	O	.	O	5	P	0

1	Single	Single	B-NP	JJ	O	3	NMOD	0
2	cell	cell	I-NP	NN	O	3	NMOD	0
3	transplants	transplant	I-NP	NNS	O	4	SUB	19	transplants
4	showed	show	B-VP	VBD	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	a	a	B-NP	DT	O	8	NMOD	0
7	common	common	I-NP	JJ	O	8	NMOD	0
8	precursor	precursor	I-NP	NN	O	9	SUB	0
9	contributes	contribute	B-VP	VBZ	O	5	SBAR	16	contributes
10	to	to	B-PP	TO	O	9	VMOD	0
11	both	both	O	CC	O	16	NMOD	0
12	the	the	B-NP	DT	O	16	NMOD	0
13	hemopoietic	hemopoietic	I-NP	JJ	B-cell_type	16	NMOD	0
14	and	and	I-NP	CC	I-cell_type	16	NMOD	0
15	endothelial	endothelial	I-NP	JJ	I-cell_type	16	NMOD	0
16	lineages	lineage	I-NP	NNS	I-cell_type	10	PMOD	0
17	,	,	O	,	O	4	P	0
18	thus	thus	B-ADVP	RB	O	19	VMOD	0
19	demonstrating	demonstrate	B-VP	VBG	O	4	VMOD	0
20	the	the	B-NP	DT	O	21	NMOD	0
21	presence	presence	I-NP	NN	O	19	OBJ	0
22	of	of	B-PP	IN	O	21	NMOD	0
23	an	an	B-NP	DT	O	25	NMOD	0
24	adult	adult	I-NP	JJ	O	25	NMOD	0
25	hemangioblast	hemangioblast	I-NP	NN	O	22	PMOD	0
26	.	.	O	.	O	4	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	increased	increase	B-NP	VBN	O	15	NMOD	17	increased
7	vascular	vascular	I-NP	JJ	B-protein	10	NMOD	0
8	endothelial	endothelial	I-NP	JJ	I-protein	10	NMOD	0
9	growth	growth	I-NP	NN	I-protein	10	NMOD	0
10	factor	factor	I-NP	NN	I-protein	15	NMOD	0
11	(	(	O	(	O	13	DEP	0
12	VEGF	VEGF	B-NP	NN	B-protein	13	DEP	0
13	)	)	O	)	O	10	NMOD	0
14	-A	-A	B-NP	NN	O	15	NMOD	0
15	secretion	secretion	I-NP	NN	O	23	NMOD	14	secretion
16	by	by	B-PP	IN	O	15	NMOD	0
17	tumor	tumor	B-NP	NN	B-cell_type	18	NMOD	0
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	0
19	,	,	O	,	O	23	P	0
20	as	as	B-CONJP	RB	O	23	NMOD	0
21	well	well	I-CONJP	RB	O	20	DEP	0
22	as	as	I-CONJP	IN	O	20	DEP	0
23	activation	activation	B-NP	NN	O	31	SUB	17	activation
24	of	of	B-PP	IN	O	23	NMOD	0
25	VEGF	VEGF	B-NP	NN	B-protein	26	NMOD	0
26	receptor-2	receptor-2	I-NP	NN	I-protein	24	PMOD	0
27	in	in	B-PP	IN	O	23	NMOD	0
28	bone	bone	B-NP	NN	B-cell_type	30	NMOD	0
29	marrow	marrow	I-NP	NN	I-cell_type	30	NMOD	0
30	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	0
31	does	do	B-VP	VBZ	O	5	SBAR	0
32	not	not	I-VP	RB	O	31	VMOD	0
33	alter	alter	I-VP	VB	O	31	VC	0
34	the	the	B-NP	DT	O	37	NMOD	0
35	mobilization	mobilization	I-NP	NN	O	37	NMOD	0
36	and	and	I-NP	CC	O	37	NMOD	0
37	incorporation	incorporation	I-NP	NN	O	33	OBJ	14	incorporation
38	of	of	B-PP	IN	O	37	NMOD	0
39	marrow-derived	marrow-derived	B-NP	JJ	B-cell_type	41	NMOD	0
40	endothelial	endothelial	I-NP	JJ	I-cell_type	41	NMOD	0
41	progenitors	progenitor	I-NP	NNS	I-cell_type	38	PMOD	0
42	into	into	B-PP	IN	O	37	NMOD	0
43	tumor	tumor	B-NP	NN	O	44	NMOD	0
44	vasculature	vasculature	I-NP	NN	O	42	PMOD	0
45	.	.	O	.	O	4	P	0

1	Finally	Finally	B-ADVP	RB	O	11	VMOD	0
2	,	,	O	,	O	11	P	0
3	in	in	B-PP	IN	O	11	VMOD	0
4	human	human	B-NP	JJ	B-cell_type	8	NMOD	0
5	umbilical	umbilical	I-NP	JJ	I-cell_type	8	NMOD	0
6	cord	cord	I-NP	NN	I-cell_type	8	NMOD	0
7	blood	blood	I-NP	NN	I-cell_type	8	NMOD	0
8	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	0
9	,	,	O	,	O	11	P	0
10	we	we	B-NP	PRP	O	11	SUB	0
11	show	show	B-VP	VBP	O	0	ROOT	0
12	that	that	B-SBAR	IN	O	11	VMOD	0
13	endothelial	endothelial	B-NP	JJ	B-cell_type	14	NMOD	0
14	precursors	precursor	I-NP	NNS	I-cell_type	15	SUB	0
15	make	make	B-VP	VBP	O	28	VMOD	0
16	up	up	B-PRT	RP	O	15	VMOD	0
17	only	only	B-NP	RB	O	28	VMOD	0
18	approximately	approximately	I-NP	RB	O	28	VMOD	0
19	1	1	I-NP	CD	O	18	OBJ	0
20	in	in	I-NP	IN	O	19	NMOD	0
21	10	10	I-NP	CD	O	26	NMOD	0
22	(	(	O	(	O	26	NMOD	0
23	7	7	B-NP	CD	O	26	NMOD	0
24	)	)	O	)	O	26	NMOD	0
25	mononuclear	mononuclear	B-NP	JJ	B-cell_type	26	NMOD	0
26	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	0
27	but	but	O	CC	O	18	VMOD	0
28	are	be	B-VP	VBP	O	12	SBAR	0
29	highly	highly	I-VP	RB	O	28	VMOD	0
30	enriched	enrich	I-VP	VBN	O	28	VC	0
31	in	in	B-PP	IN	O	30	VMOD	0
32	the	the	B-NP	DT	O	35	NMOD	0
33	CD133+	CD133+	I-NP	JJ	B-cell_line	35	NMOD	0
34	cell	cell	I-NP	NN	I-cell_line	35	NMOD	0
35	population	population	I-NP	NN	I-cell_line	31	PMOD	0
36	.	.	O	.	O	11	P	0

1	By	By	B-PP	IN	O	9	VMOD	0
2	ruling	rule	B-VP	VBG	O	1	PMOD	0
3	out	out	B-PRT	RP	O	2	VMOD	0
4	cell	cell	B-NP	NN	O	5	NMOD	0
5	fusion	fusion	I-NP	NN	O	2	OBJ	2	fusion
6	,	,	O	,	O	9	P	0
7	we	we	B-NP	PRP	O	9	SUB	0
8	clearly	clearly	B-ADVP	RB	O	9	VMOD	0
9	demonstrate	demonstrate	B-VP	VBP	O	28	VMOD	0
10	the	the	B-NP	DT	O	11	NMOD	0
11	existence	existence	I-NP	NN	O	9	OBJ	14	existence
12	of	of	B-PP	IN	O	11	NMOD	0
13	an	an	B-NP	DT	O	15	NMOD	0
14	adult	adult	I-NP	JJ	O	15	NMOD	0
15	hemangioblast	hemangioblast	I-NP	NN	O	12	PMOD	0
16	,	,	O	,	O	28	P	0
17	but	but	O	CC	O	28	VMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	differentiation	differentiation	I-NP	NN	O	28	SUB	2	differentiation
20	of	of	B-PP	IN	O	19	NMOD	0
21	marrow	marrow	B-NP	NN	B-cell_type	23	NMOD	0
22	stem	stem	I-NP	NN	I-cell_type	23	NMOD	0
23	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	0
24	toward	toward	B-PP	IN	O	19	NMOD	0
25	the	the	B-NP	DT	O	27	NMOD	0
26	endothelial	endothelial	I-NP	JJ	B-cell_type	27	NMOD	0
27	lineage	lineage	I-NP	NN	I-cell_type	24	PMOD	0
28	is	be	B-VP	VBZ	O	0	ROOT	0
29	an	an	B-NP	DT	O	32	NMOD	0
30	extremely	extremely	I-NP	RB	O	31	AMOD	0
31	rare	rare	I-NP	JJ	O	32	NMOD	0
32	event	event	I-NP	NN	O	28	PRD	0
33	.	.	O	.	O	28	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	show	show	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	VEGF-A	VEGF-A	B-NP	NN	B-protein	7	NMOD	0
7	stimulation	stimulation	I-NP	NN	O	11	SUB	17	stimulation
8	of	of	B-PP	IN	O	7	NMOD	0
9	hemopoietic	hemopoietic	B-NP	JJ	B-cell_type	10	NMOD	0
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	0
11	does	do	B-VP	VBZ	O	5	SBAR	0
12	not	not	I-VP	RB	O	11	VMOD	0
13	significantly	significantly	I-VP	RB	O	11	VMOD	0
14	alter	alter	I-VP	VB	O	11	VC	0
15	this	this	B-NP	DT	O	16	NMOD	0
16	process	process	I-NP	NN	O	14	OBJ	0
17	.	.	O	.	O	4	P	0

